Subthalamic Steering for Therapy Optimization in Parkinson's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alireza Gharabaghi, MD
Division of Functional and Restorative Neurosurgery, Department of Neurosurgery, Tuebingen, Germany
Principal Investigator - Daniel Weiss, MD
Department for Neurodegenerative Diseases, Centre for Neurology, Tuebingen, Germany, and Hertie-Institute for Clinical Brain Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospital Tuebingen, Dep. of Neurosurgery (functional Neurosurgery) and Neurology (neurodegenerative Diseases)
Tübingen, Baden-Wurttemberg, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Apr 2018
- Primary completion
- 31 Dec 2023
- Completion
- 31 Dec 2023
- Last update posted
- 3 Jun 2026
- Registered enrollment
- 20
- Registry id
- NCT03548506
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.